Work

Plasmodium vivax elimination from India may need therapeutic efficacy studies - Informed shift to artemisinin-based treatment

Year: 2025

Type: article

Abstract: . We argue that India may prioritize TES expansion and adopt an ACT-based regimen to sustain its elimination momentum and prevent therapeutic failure.

Source: IJID Regions

DOI: 10.1016/j.ijregi.2025.100822

Authors: Meghavi Kathpalia, Loick P. Kojom Foko, Pragya Rawat, Rini Chaturvedi, Manju Rahi, Amit Sharma

Institutions: International Centre for Genetic Engineering and Biotechnology, Indian Institute of Science Education and Research Berhampur, All India Institute of Medical Sciences, Indian Council of Medical Research, Vector Control Research Centre

Language: English

Topic: Malaria Research and Control

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,380

Funders: Department of Science and Technology, Ministry of Science and Technology, India, University Grants Commission

Awards: G6913419799, G8490474871

OpenAlex ID: W4416971716

FWCI:

Cites: 35

Cited by:

Related to: